Journal
NATURE IMMUNOLOGY
Volume 7, Issue 6, Pages 606-615Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni1334
Keywords
-
Categories
Funding
- Medical Research Council [MC_U117512796, MC_U117565642, MC_U117527252] Funding Source: Medline
- Medical Research Council [U117532003, MC_U117512796, MC_U117527252, MC_U117565642] Funding Source: researchfish
- MRC [MC_U117565642, MC_U117527252, MC_U117512796] Funding Source: UKRI
Ask authors/readers for more resources
The TPL-2 MEK kinase is essential for activation of the Erk MAP kinase pathway during innate immune responses. TPL-2 is found in complex with ABIN-2 (A20-binding inhibitor of NF-kappa B 2). Here, using antigen-presenting cells from ABIN-2-deficient mice, we show that ABIN-2 was required for optimal activation of Erk induced by receptors that signal via TPL-2, including Toll-like receptor 4 and tumor necrosis factor receptor 1 in macrophages, and CD40 in B cells. ABIN-2 was necessary for the maintenance of TPL-2 protein stability. In contrast, ABIN-2 deficiency did not affect agonist-induced regulation of transcription factor NF-kappa B. Stimulation of ABIN-2-deficient macrophages via Toll-like receptor 4 showed that different thresholds of Erk signaling were required for optimal induction of tumor necrosis factor and interleukin 1 beta. Thus, ABIN-2 acts to positively regulate the Erk signaling potential by stabilizing TPL-2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available